Veradermics MANE
NYSE MANE
$148.41 +4.46 (+3.10%)
As of: Nov 10, 2026 · 12:35 PM EST

Veradermics (MANE) Common Equity (2024 - 2026)

Updated

Veradermics (MANE) recorded Common Equity of $813.61 million in Q2 2026, compared with -$76.07 million a year earlier and up 108.3% from the prior quarter.

Analysis

Veradermics (MANE) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Veradermics reported Common Equity of -$121.01 million.

  • Across earlier years, Common Equity came in at -$48.48 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 81.53 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -4.58 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 50.37 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 13.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 89.30 Bn
10 Veradermics 6.01 Bn 4.61 Bn - 813.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 813.61 Mn
Mar 31, 2026 390.64 Mn
Dec 31, 2025 -121.01 Mn
Jun 30, 2025 -76.07 Mn
Mar 31, 2025 -60.67 Mn
Dec 31, 2024 -48.48 Mn
API Access

Veradermics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=MANE&period=max&api_key=YOUR_API_KEY